Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance
PHASE3
The investigators propose this study utilizing Lenalidomide, Adriamycin, De...
Status
Unknown
Location
UniversitÀtsklinikum Aachen, Med. Klinik IV, HÀmatologie u. Onkologie
Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation
PHASE1
Primary Objectives:
* VCDI cohort:
* To determine the maximum tolerated...
Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma
PHASE2
In view of the synergistic effects of rituximab, zanubrutinib, and lenalido...